✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Gliolan is an investigational drug.
There have been 16 clinical trials for Gliolan. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Glioblastoma, Brain Neoplasms, and Glioma. The leading clinical trial sponsors are photonamic GmbH & Co. KG, National Cancer Institute (NCI), and Constantinos Hadjipanayis.
Recent Clinical Trials for Gliolan
|Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma||Hemerion Therapeutics||Phase 2|
|Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma||Institut National de la Santé Et de la Recherche Médicale, France||Phase 2|
|Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma||University Hospital, Lille||Phase 2|